Skip to content

LIGHT (Lifestyle Intervention in the memory clinics of General and academic Hospitals Trial): Secondary prevention of dementia in memory clinics: implementation and (cost-) effectiveness of an integrated lifestyle intervention

LIGHT (Lifestyle Intervention in the memory clinics of General and academic Hospitals Trial): Secondary prevention of dementia in memory clinics: implementation and (cost-) effectiveness of an integrated lifestyle intervention - LIGHT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57198
Enrollment
300
Registered
2024-03-22
Start date
2025-03-18
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia risk profile

Interventions

Participants are randomly allocated on a 1:1 ratio to participate either in Group A (tailored lifestyle intervention) or Group B (general health advice) for a duration of 12 months. The lifestyle in

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Being >=50 years; 2) Having a diagnosis of SCD or MCI; 3) Having at least two modifiable risk factors for dementia

Exclusion criteria

Exclusion criteria: 1) Having a diagnosis of dementia; 2) Conditions affecting safe and continuous engagement in the intervention (e.g. under treatment for current malignant diseases, major psychiatric disorders (e.g. major de-pression, psychosis, bipolar disorder), other conditions preventing co-operation as judged by the local study nurse or consulted physician at the local study site; 3) Participation in any other intervention study at time of pre-screening. 4) Insufficient understanding of the Dutch language

Design outcomes

Primary

MeasureTime frame
The primary outcome will be change in participants* dementia risk profile as measured by the LIfestyle for BRAin Health (LIBRA) score between baseline and 12 months.

Secondary

MeasureTime frame
Secondary outcomes include cognitive functions (episodic memory, executive functions, information processing speed, and attention). Other secondary outcomes include measures of body mass index (height and weight), office systolic and diastolic blood pressure, and lab measures including cholesterol levels (total, HDL, LDL, triglycerides), HbA1c levels, creatinine-based eGFR levels. Smoking, alcohol intake and current relevant medical conditions (coronary heart disease, kidney disease, type 2 diabetes, depression, hearing loss, sleep disorders) will be assessed through self-report. Additional questionnaires include health-related quality of life and capabilities, instrumental activities of daily living, health locus of control, self-efficacy, mastery, healthy diet, physical activity, cognitive stimulation, stress, and depressive symptoms, sleep quality, social support and feelings of loneliness, and lastly knowledge on dementia risk and protective factors. For cost-effectiveness, questionnaires on resource utilization, medical consumption, and productivity costs are administered. Additional measures include change in diagnosis (if applicable), demographics (age, sex, educational level, socioeconomic position (household income), paid/voluntary work hours, ethnicity, marital status, living situation), medication use, hearing loss. For process evaluation, questionnaires and interviews are administered on implementation, mechanisms of impact and contact (e.g., appointments with lifestyle coach, use of the breinzorg.nl self-management tool, use of the voucher program, experiences and usefulness, etc.).

Countries

Netherlands

Contacts

Public ContactN Janssen

Universiteit Maastricht

niels.janssen@maastrichtuniversity.nl0657263050

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026